Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in INKT held by the largest 10 / 25 filers.
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in INKT β a direct measure of their conviction.
Filings activity in INKT during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new INKT position in Q1 2026
Institutions that fully closed their INKT position in Q1 2026
5 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 21 | 4.5% | 2.21% | 4.58 pp | $1M | 67% |
| Q4 2025 | 22 | +22% | 6.79% | +4.66 pp | $4M | +219% |
| Q3 2025 | 18 | 5.3% | 2.13% | +1.36 pp | $1M | +178% |
| Q2 2025 | 19 | +12% | 0.77% | 0.11 pp | $0M | 13% |
| Q1 2025 | 17 | β | 0.88% | β | $1M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying INKT stock.
Based on Q1 2026 13F filings, institutional ownership of MiNK Therapeutics, Inc. stands at 2.2%, held across 21 reporting institutions.
VANGUARD CAPITAL MANAGEMENT LLC is the largest reported institutional holder of INKT, with approximately 59,364 shares worth $0.00B as of Q1 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of INKT.
Our composite Smart Money Score for INKT is 22 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
5 institutions opened new positions in INKT during Q1 2026, while 6 fully exited. 2 added to existing positions and 12 trimmed.
INKT institutional ownership fell by 4.58 percentage points quarter-over-quarter, with a net change of -1 holders.
The top 10 institutions account for 99.9% of all reported 13F value in INKT, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
MiNK Therapeutics, Inc. (INKT) Institutional Ownership